european INDUSTRIAL PHARMACY ISSUE 17 • JUNE 2013 www.industrialpharmacy.eu www.eipg.eu features 4 STABLE CYTOCHROME P450 ENZYMES FOR TOXICITY AND METABOLISM TESTING Researchers…

european INDUSTRIAL PHARMACY ISSUE 20 • MARCH 2014 www.industrialpharmacy.eu www.eipg.eu features 4 UNSTANDARD STANDARDS The need for a single worldwide accepted pharmacopoeia…

european INDUSTRIAL PHARMACY ISSUE 9 • JUNE 2011 www.industrialpharmacy.eu www.eipg.eu FEATURES 4 FORMULATION AND DELIVERY OF CANNABINOIDS The poor solubility of cannabinoids…

ISSUE 12 • MARCH 2012 www.industrialpharmacy.eu www.eipg.eu european INDUSTRIAL PHARMACY features 4 THE BREAST IMPLANT SCANDAL AND EUROPEAN MEDICAL DEVICE REGULATION The…

ISSUE 23 • DECEMBER 2014 www.industrialpharmacy.eu www.eipg.eu features 4 ACHIEVING BIOSIMILAR PRODUCT APPROVAL – KEY SUCCESS FACTORS FOR DEVELOPMENT Biosimilars have…

european INDUSTRIAL PHARMACY ISSUE 22 • SEPTEMBER 2014 www.industrialpharmacy.eu www.eipg.eu features 4 SUPPLEMENTARY PROTECTION CERTIFICATES: OF CLARITY AND CONFUSION…